Raymond James Financial
BHVN icon

Raymond James Financial’s Biohaven BHVN Stock Holding History

Raymond James Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.78M Buy
446,611
+9,815
+2% +$107K ﹤0.01% 2814
2025
Q4 		$4.93M Buy
436,796
+344,751
+375% +$4.27M ﹤0.01% 2524
2025
Q3 		$1.38M Buy
92,045
+59,431
+182% +$865K ﹤0.01% 3458
2025
Q2 		$460K Buy
32,614
+9,443
+41% +$168K ﹤0.01% 4061
2025
Q1 		$557K Sell
23,171
-13,862
-37% -$489K ﹤0.01% 3877
2024
Q4 		$1.38M Buy
+37,033
New +$1.73M ﹤0.01% 3232

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's BHVN Position: Q1 2026 in Review

Raymond James Financial increased its Biohaven (BHVN) stake by 2.2% in Q1 2026, buying an estimated $107K and bringing the position to 446,611 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

Raymond James Financial first reported a position in BHVN in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.93M in Q4 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Raymond James Financial held 446,611 shares of Biohaven worth $3.78M as of Q1 2026.
  • Raymond James Financial bought 9,815 Biohaven shares in Q1 2026, an estimated $107K.
  • Biohaven made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2814 holding.
  • Raymond James Financial first reported a position in Biohaven in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Biohaven position peaked at $4.93M in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.